Services on Demand
Journal
Article
English (pdf)
Article in xml format
Article references
Automatic translation
Send this article by e-mailIndicators
Cited by SciELO 
Access statistics
Related links
Similars in
SciELO
Share
Permalink
Revista mexicana de angiología
On-line version ISSN 2696-130XPrint version ISSN 0377-4740
Abstract
GONZALEZ-FREGOSO, Raúl; LEO-AMADOR, Guillermo E. and GARCIA-GIL, Lourdes. Rivaroxaban for thromboprophylaxis after venous ablation with radiofrequency in the saphenous femoral and saphenous popliteal junction. Rev. mex. angiol. [online]. 2019, vol.47, n.4, pp.49-52. Epub Oct 25, 2021. ISSN 2696-130X. https://doi.org/10.24875/rma.19000014.
Objective:
The objective of the study was to compare the prevalence of endovenous heat-induced thrombosis (EHIT) in thromboprophylaxis with rivaroxaban versus none thromboprophylaxis in ablation with radiofrequency (RF) ablation.
Methods:
A retrospective, observational design of cases and controls of patients with chronic venous insufficiency was reviewed after the procedure of truncal ablation with RF. Group 1 did not receive thromboprophylaxis after the surgery. Group 2 received 10 mg of rivaroxaban every 24 h for a 2-week period. The presence of EHIT was evaluated during the 3rd and 7th days of post-surgery.
Results:
Between January 2013 and December 2017, a total of 113 patients were evaluated with 132 procedures. As a result, we found a significant difference in the total of procedures in favor of thromboprophylaxis with rivaroxaban decreasing the EHIT by p ≤ 0.0031 and odds ratio 8.5 with a confidence interval of 95% (2.10-39.9).
Conclusion:
The use of rivaroxaban was effective in the thromboprophylaxis of EHIT in the venous ablation with RF.
Keywords : Endovenous heat-induced thrombosis; Radiofrequency; Rivaroxaban; Thromboprophylaxis; Venous ablation.
